+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Montelukast Sodium Granules Market by Application (Asthma, Exercise Induced Bronchoconstriction, Perennial Allergic Rhinitis), Patient Age Group (Adult, Pediatric), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030- Product Image
Montelukast Sodium Granules Market by Application (Asthma, Exercise Induced Bronchoconstriction, Perennial Allergic Rhinitis), Patient Age Group (Adult, Pediatric), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030- Product Image
New

Montelukast Sodium Granules Market by Application (Asthma, Exercise Induced Bronchoconstriction, Perennial Allergic Rhinitis), Patient Age Group (Adult, Pediatric), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146835
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
As the prevalence of respiratory and allergic conditions continues to rise across age groups, Montelukast Sodium Granules have emerged as a pivotal intervention in comprehensive patient management strategies. Designed to deliver precise dosing and enhanced palatability for pediatric and adult populations alike, this formulation addresses longstanding adherence challenges associated with traditional tablet forms. Furthermore, its integration into combination therapy regimens has underscored its relevance for patients with complex comorbidities, driving clinical interest and prompting deeper exploration into formulation advancements.

Building upon these clinical imperatives, this report delves into the multifaceted landscape of Montelukast Sodium Granules, examining evolving patient preferences, regulatory shifts, and manufacturing innovations. Through a rigorous analytical framework, readers will gain clarity on the mechanisms that influence therapeutic adoption, distribution dynamics, and the strategic initiatives undertaken by key stakeholders. This introduction sets the foundation for actionable insights that span segmentation analyses, regional performance evaluations, competitive benchmarks, and forward-looking recommendations.

Identifying Key Drivers and Disruptive Forces Responsible for Transforming the Montelukast Sodium Granules Market Landscape Globally

Rapid technological advancements, shifting payer paradigms, and intensified focus on personalized medicine have collectively redefined the competitive contours of Montelukast Sodium Granules. As digital health platforms facilitate telemedicine consultations and remote monitoring, patient engagement has grown more robust, prompting manufacturers to explore packaging innovations that enable integrated adherence tracking. In addition, regulatory agencies are streamlining approval pathways for pediatric-friendly formulations, accelerating the introduction of novel granule compositions designed to optimize bioavailability while minimizing excipient load.

Moreover, escalating interest in value-based reimbursement models is driving industry players to demonstrate real-world efficacy through post-marketing surveillance studies and outcomes-based evidence generation. Against this backdrop, the entrance of biosimilar and generic equivalents is intensifying price sensitivity, compelling established brands to reinforce patient support programs and invest in brand differentiation. Collectively, these forces are fostering a dynamic environment where agility, patient-centric innovation, and strategic partnerships are paramount to maintaining market relevance.

Analyzing the Far-Reaching Consequences of United States Tariff Adjustments on Montelukast Sodium Granules Supply Chains and Pricing Mechanisms in 2025

The introduction of revised import tariffs in the United States during 2025 has introduced new pressure points across the global supply chain for Montelukast Sodium Granules. By elevating costs on active pharmaceutical ingredient shipments originating from key manufacturing hubs, these measures have triggered immediate reassessments of sourcing strategies among drug producers. Consequently, procurement teams are exploring alternative suppliers in tariff-exempt jurisdictions, while logistics divisions are recalibrating their distribution networks to mitigate incremental freight and regulatory expenses.

In response, several industry leaders have accelerated initiatives to localize critical manufacturing processes, including formulation, granulation, and packaging within North American facilities. Such near-shoring efforts are designed to insulate supply chains from future tariff volatility, enhance production agility, and reduce lead times. Meanwhile, finance and pricing committees are revisiting contractual agreements with wholesalers and distributors to realign margin structures under the new tariff regime. These adaptive measures underscore the strategic imperative of maintaining cost competitiveness without compromising quality or supply continuity.

Uncovering In-Depth Segmentation Insights by Application Patient Age Distribution Channel End User and Dosage Strength for Enhanced Strategic Planning

Segmentation analysis reveals that Montelukast Sodium Granules play a critical role in treating asthma as well as exercise-induced bronchoconstriction, perennial allergic rhinitis, and seasonal allergic rhinitis, reflecting a broad therapeutic application profile. Equally important is the patient age group dimension, which distinguishes adult use from pediatric administration, with children between 2 to 5 years and those aged 6 to 14 years exhibiting distinct dosing requirements and adherence patterns. This clarity on age-specific preferences informs formulation design and packaging innovations to enhance acceptability and compliance among younger patients.

In addition, evaluation of distribution channels highlights the growing significance of hospital pharmacy procurement alongside expanding online pharmacy platforms and established retail pharmacy networks, each offering unique reach and patient engagement opportunities. End users span clinic-based dispensing, home care settings supported by caregiver administration, and hospital inpatient environments requiring stringent quality controls. Finally, dosage strength analysis comparing 4 milligram and 5 milligram offerings underscores the importance of flexible prescribing options that align with clinician recommendations and pediatric dosing protocols.

Revealing Regional Performance Dynamics for Montelukast Sodium Granules Across the Americas Europe Middle East & Africa and Asia-Pacific to Guide Market Expansion

Regional analysis underscores divergent attributes across the Americas, characterized by mature reimbursement frameworks, robust generics penetration, and established patient support infrastructures that facilitate rapid uptake of new formulations. Meanwhile, Europe, Middle East & Africa present a mosaic of regulatory environments and purchasing mechanisms, where value assessments and health technology appraisals exert significant influence over formulary inclusion and reimbursement levels. In contrast, Asia-Pacific markets exhibit high growth potential fueled by expanding healthcare access, rising allergy incidence, and increasing investment in pediatric healthcare services.

These regional dynamics necessitate tailored market entry and expansion strategies. In the Americas, manufacturers may prioritize lifecycle management and patient assistance programs to maintain differentiation, whereas in Europe, Middle East & Africa, collaboration with government agencies and payers will be essential to navigate varying regulatory pathways and health economics requirements. Likewise, in Asia-Pacific, forging alliances with local contract manufacturers and leveraging digital dispensing platforms can accelerate distribution and patient outreach. Understanding these nuances is critical for optimizing resource allocation and maximizing commercial impact across diverse geographical landscapes.

Profiling Industry Leading Players Delivering Innovation Operational Excellence and Strategic Growth in the Montelukast Sodium Granules Sector

Global biopharmaceutical corporations and specialized generic manufacturers are aggressively positioning Montelukast Sodium Granules within their respiratory and allergy portfolios. Key incumbents have demonstrated expertise in pediatric formulation technology, leveraging polymer-based coating techniques to mask bitterness and improve palatability. Meanwhile, generic leaders are streamlining production processes to achieve cost leadership, employing continuous manufacturing platforms that offer scalability and regulatory compliance for high-volume granule output.

Strategic growth is further supported by targeted investments in clinical programs that validate real-world effectiveness and adherence outcomes. Partnerships between originators and contract development and manufacturing organizations have also emerged as a prominent trend, enabling rapid capacity expansion and cost optimization. In addition, some players are exploring value-added services such as digital inhalation trackers and adherence analytics to complement the granule formulation, reinforcing patient engagement and strengthening brand loyalty in competitive markets.

Articulating High-Impact Actionable Recommendations to Strengthen Market Positioning and Drive Sustainable Growth in Montelukast Sodium Granules Commercial Strategies

To thrive in an increasingly complex environment, manufacturers should prioritize the localization of critical supply chain operations, ensuring resilience against policy shifts and logistical disruptions. Concurrently, adopting digital engagement platforms that support remote patient monitoring and adherence incentives will help differentiate offerings in both mature and emerging markets. Fostering collaborations with pediatric specialists and allergy clinics can generate real-world evidence to substantiate improved outcomes, thereby enhancing formulary negotiations and reimbursement positioning.

Moreover, integrating value-based contracting models that align pricing with measured patient adherence and clinical benefits will resonate with payers focused on sustainable healthcare spending. R&D investments should center on novel excipient technologies and taste-masking approaches to address pediatric adherence challenges. Finally, expanding into underserved regions through strategic alliances with local distributors can accelerate market penetration while ensuring compliance with diverse regulatory frameworks.

Detailing Rigorous Research Methodology Combining Data Sourcing Analytical Frameworks and Quality Assurance Protocols Underpinning the Market Study

This analysis is built on a multi-tiered research methodology that combines extensive secondary research from proprietary scientific journals, regulatory filings, and aggregated patent databases. Complementing these sources, primary interviews with industry executives, clinical experts, and supply chain specialists provided nuanced perspectives on emerging trends and operational challenges. Rigorous data triangulation and cross-validation processes were applied to ensure consistency and reliability of the insights presented.

Analytical frameworks such as SWOT assessments, competitive intensity evaluations, and scenario analyses underpin the strategic findings. Quality assurance protocols, including peer review by subject matter experts and iterative validation cycles, guarantee methodological rigor. By adopting this structured approach, the report delivers actionable intelligence that guides decision-making across product development, market entry, and competitive strategy.

Synthesizing Key Findings and Insights to Highlight Strategic Imperatives Shaping the Future of the Montelukast Sodium Granules Market

The synthesis of clinical adoption factors, regulatory shifts, and supply chain dynamics reveals a market landscape defined by rapid evolution and nuanced regional variation. Segmentation insights highlight the critical importance of age-specific formulations and distribution channel diversity, while the 2025 tariff changes emphasize the necessity of supply chain resilience and localization. Company profiles underscore the ongoing pursuit of innovation through formulation enhancements, digital patient support mechanisms, and strategic partnerships.

Collectively, these findings point to strategic imperatives for stakeholders: maintain agility in response to policy changes, invest in patient-centric formulation technologies, and deploy data-driven engagement tools to strengthen brand differentiation. By aligning commercial strategies with emerging payer models and localized market requirements, industry participants can capitalize on growth opportunities while mitigating potential disruptions. This conclusion underscores the value of a holistic approach to sustaining competitive advantage moving forward.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Asthma
    • Exercise Induced Bronchoconstriction
    • Perennial Allergic Rhinitis
    • Seasonal Allergic Rhinitis
  • Patient Age Group
    • Adult
    • Pediatric
      • 2 To 5 Years
      • 6 To 14 Years
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Clinic
    • Home Care
    • Hospital
  • Dosage Strength
    • 4 Milligram
    • 5 Milligram
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Merck & Co., Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Sandoz Inc.
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Apotex Inc.
  • Cipla Limited
  • Aurobindo Pharma Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of telemedicine-driven prescription of montelukast sodium granules for pediatric asthma management
5.2. Growing clinical trials investigating sublingual montelukast sodium granules formulations for enhanced drug bioavailability
5.3. Strategic partnerships between generic drug manufacturers to scale montelukast sodium granules production in emerging markets
5.4. Regulatory approvals driving expanded montelukast sodium granules use in allergy prophylaxis beyond asthma treatment
5.5. Emerging pediatric adherence programs leveraging flavored montelukast sodium granules to reduce asthma exacerbation rates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Montelukast Sodium Granules Market, by Application
8.1. Introduction
8.2. Asthma
8.3. Exercise Induced Bronchoconstriction
8.4. Perennial Allergic Rhinitis
8.5. Seasonal Allergic Rhinitis
9. Montelukast Sodium Granules Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.3. Pediatric
9.3.1. 2 To 5 Years
9.3.2. 6 To 14 Years
10. Montelukast Sodium Granules Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Montelukast Sodium Granules Market, by End User
11.1. Introduction
11.2. Clinic
11.3. Home Care
11.4. Hospital
12. Montelukast Sodium Granules Market, by Dosage Strength
12.1. Introduction
12.2. 4 Milligram
12.3. 5 Milligram
13. Americas Montelukast Sodium Granules Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Montelukast Sodium Granules Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Montelukast Sodium Granules Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Teva Pharmaceuticals USA, Inc.
16.3.3. Sandoz Inc.
16.3.4. Viatris Inc.
16.3.5. Dr. Reddy’s Laboratories Ltd.
16.3.6. Sun Pharmaceutical Industries Ltd.
16.3.7. Glenmark Pharmaceuticals Ltd.
16.3.8. Apotex Inc.
16.3.9. Cipla Limited
16.3.10. Aurobindo Pharma Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MONTELUKAST SODIUM GRANULES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MONTELUKAST SODIUM GRANULES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MONTELUKAST SODIUM GRANULES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MONTELUKAST SODIUM GRANULES MARKET: RESEARCHAI
FIGURE 26. MONTELUKAST SODIUM GRANULES MARKET: RESEARCHSTATISTICS
FIGURE 27. MONTELUKAST SODIUM GRANULES MARKET: RESEARCHCONTACTS
FIGURE 28. MONTELUKAST SODIUM GRANULES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MONTELUKAST SODIUM GRANULES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY EXERCISE INDUCED BRONCHOCONSTRICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY EXERCISE INDUCED BRONCHOCONSTRICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PERENNIAL ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 2 TO 5 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 2 TO 5 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 6 TO 14 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 6 TO 14 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 4 MILLIGRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 4 MILLIGRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 5 MILLIGRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY 5 MILLIGRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 86. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 87. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. CANADA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 98. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 99. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 104. MEXICO MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 160. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 161. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. GERMANY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 172. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 173. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. FRANCE MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 196. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 197. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. ITALY MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 208. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 209. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. SPAIN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 251. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 256. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 257. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. DENMARK MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 275. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 280. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 281. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. QATAR MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 291. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 292. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 293. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 298. FINLAND MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN MONTELUKAST SODIUM GRANULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MONTELUKAST SODIUM GRANULES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA M

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Montelukast Sodium Granules market report include:
  • Merck & Co., Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Sandoz Inc.
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Apotex Inc.
  • Cipla Limited
  • Aurobindo Pharma Ltd.

Related Topics

Related Reports

Montelukast Sodium Market by Formulation (Chewable Tablet, Oral Granules, Tablet), Dosage Strength (10mg, 4mg, 5mg), Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Montelukast Sodium Market by Formulation (Chewable Tablet, Oral Granules, Tablet), Dosage Strength (10mg, 4mg, 5mg), Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Montelukast Sodium Market Report 2025 - Product Image

Montelukast Sodium Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Montelukast Sodium - Global Strategic Business Report - Product Image

Montelukast Sodium - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Montelukast Sodium Market - Product Image

Montelukast Sodium Market

  • Report
  • 200 Pages
  • Global
From
Montelukast Sodium - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Montelukast Sodium - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.